BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Krey L, Huber MK, Höglinger GU, Wegner F. Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson's Disease? Brain Sci 2021;11:1654. [PMID: 34942956 DOI: 10.3390/brainsci11121654] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Al-Kuraishy HM, Al-Gareeb AI, Kaushik A, Kujawska M, Ahmed EA, Batiha GE. SARS-COV-2 infection and Parkinson's disease: Possible links and perspectives. J Neurosci Res 2023. [PMID: 36717481 DOI: 10.1002/jnr.25171] [Reference Citation Analysis]
2 Huang P, Zhang LY, Tan YY, Chen SD. Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms. Transl Neurodegener 2023;12:5. [PMID: 36717892 DOI: 10.1186/s40035-023-00337-1] [Reference Citation Analysis]
3 Zhang J. Investigating neurological symptoms of infectious diseases like COVID-19 leading to a deeper understanding of neurodegenerative disorders such as Parkinson's disease. Front Neurol 2022;13:968193. [PMID: 36570463 DOI: 10.3389/fneur.2022.968193] [Reference Citation Analysis]
4 Scherbaum R, Bartig D, Richter D, Kwon EH, Muhlack S, Gold R, Krogias C, Tönges L. COVID-19 outcomes in hospitalized Parkinson’s disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany. Neurol Res Pract 2022;4:27. [DOI: 10.1186/s42466-022-00192-x] [Reference Citation Analysis]
5 Chaumont H, Kaczorowski F, San-Galli A, Michel PP, Tressières B, Roze E, Quadrio I, Lannuzel A. Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes. Rev Neurol (Paris) 2022:S0035-3787(22)00821-9. [PMID: 36610823 DOI: 10.1016/j.neurol.2022.11.002] [Reference Citation Analysis]
6 Asadollahzade E, Ghadiri F, Ebadi Z, Moghadasi AN. Comment on "The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging". Rev Assoc Med Bras (1992) 2022;68:1624-5. [PMID: 36449811 DOI: 10.1590/1806-9282.20221201] [Reference Citation Analysis]
7 Zhao Y, Jaber VR, Lukiw WJ. SARS-CoV-2, long COVID, prion disease and neurodegeneration. Front Neurosci 2022;16:1002770. [DOI: 10.3389/fnins.2022.1002770] [Reference Citation Analysis]
8 Shalash A, Helmy A, Salama M, Gaber A, El-belkimy M, Hamid E. A 6-month longitudinal study on worsening of Parkinson’s disease during the COVID-19 pandemic. npj Parkinsons Dis 2022;8:111. [DOI: 10.1038/s41531-022-00376-x] [Reference Citation Analysis]
9 Paidas MJ, Cosio DS, Ali S, Kenyon NS, Jayakumar AR. Long-Term Sequelae of COVID-19 in Experimental Mice. Mol Neurobiol 2022. [PMID: 35831558 DOI: 10.1007/s12035-022-02932-1] [Reference Citation Analysis]
10 Cavallieri F, Fioravanti V, Bove F, Del Prete E, Meoni S, Grisanti S, Zedde M, Pascarella R, Moro E, Valzania F. COVID-19 and Parkinsonism: A Critical Appraisal. Biomolecules 2022;12:970. [DOI: 10.3390/biom12070970] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Dedoni S, Avdoshina V, Camoglio C, Siddi C, Fratta W, Scherma M, Fadda P. K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research. Molecules 2022;27:4142. [DOI: 10.3390/molecules27134142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhao Y, Lukiw WJ. SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease. Front Cell Neurosci 2022;16:937961. [DOI: 10.3389/fncel.2022.937961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Matschke J, Lahann H, Krasemann S, Altmeppen H, Pfefferle S, Galliciotti G, Fitzek A, Sperhake J, Ondruschka B, Busch M, Rotermund N, Schulz K, Lohr C, Dottermusch M, Glatzel M. Young COVID-19 Patients Show a Higher Degree of Microglial Activation When Compared to Controls. Front Neurol 2022;13:908081. [DOI: 10.3389/fneur.2022.908081] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Szabo MP, Iba M, Nath A, Masliah E, Kim C. Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS. Exp Mol Med 2022;54:447-54. [PMID: 35396576 DOI: 10.1038/s12276-022-00755-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
15 Heumüller S, Vorberg IM. Möglicher Einfluss von Viren auf die Ausbreitung von Proteinaggregaten. Biospektrum 2022;28:162-164. [DOI: 10.1007/s12268-022-1730-9] [Reference Citation Analysis]
16 Rota S, Boura I, Wan Y, Lazcano-ocampo C, Rodriguez-violante M, Antonini A, Chaudhuri KR. Spotlight on non-motor symptoms and Covid-19. International Review of Neurobiology 2022. [DOI: 10.1016/bs.irn.2022.04.001] [Reference Citation Analysis]